Havrljenko Jelena, Kopitovic Vesna, Trninic Pjevic Aleksandra, Milatovic Stevan, Kalember Sandro, Katanic Filip, Pavlica Tatjana, Andric Nebojsa, Pogrmic-Majkic Kristina
Ferona Fertility Clinic, Sarplaninska 19, 21000 Novi Sad, Serbia.
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovica 2, 21000 Novi Sad, Serbia.
J Clin Med. 2025 Mar 17;14(6):2026. doi: 10.3390/jcm14062026.
Poor responder patients represent the greatest challenge in ART. An inadequate response to COS strongly correlates with a reduced chance of conception. A novel classification of poor responders overcame a deficiency in the Bologna criteria and distinguished an expected and unexpected low ovarian response, allowing for an individual treatment approach to be created. In this study, we compared the clinical outcomes in poor responders, according to two different ovarian stimulation protocols, GnRH agonists and antagonists, classified according to the Poseidon criteria, to determine the most effective protocol for each group. This retrospective study involved 1323 low-prognosis women ranked according to the Poseidon classification and a control group of normal responders. The GnRH-antagonist protocol showed some advantage in the Poseidon 1b group whereas the GnRH-agonist protocol was more effective in the Poseidon 4 group. There were no differences in live births or miscarriage rates in poor responders among these two protocols. Using both the agonist/antagonist approaches, live birth rates are two or even three times less in Poseidon patients in comparison to normal responders. The number of obtained oocytes, their maturity and quality, and women's ages were found to be the most influential determinants for a successful outcome. Further investigations into ovarian stimulation strategies are required to enhance oocyte number and live birth occurrence.
反应不良的患者是辅助生殖技术(ART)中最大的挑战。对控制性卵巢刺激(COS)反应不足与受孕几率降低密切相关。一种新的反应不良者分类方法克服了博洛尼亚标准的缺陷,区分了预期和意外的低卵巢反应,从而能够制定个性化的治疗方案。在本研究中,我们根据两种不同的卵巢刺激方案(促性腺激素释放激素(GnRH)激动剂和拮抗剂),对根据波塞冬标准分类的反应不良者的临床结局进行比较,以确定每组最有效的方案。这项回顾性研究纳入了1323名根据波塞冬分类法划分的低预后女性以及一个正常反应者对照组。GnRH拮抗剂方案在波塞冬1b组显示出一些优势,而GnRH激动剂方案在波塞冬4组更有效。这两种方案在反应不良者的活产率或流产率方面没有差异。与正常反应者相比,使用激动剂/拮抗剂方法时,波塞冬患者的活产率低两倍甚至三倍。获得的卵母细胞数量、其成熟度和质量以及女性年龄被发现是成功结局的最有影响的决定因素。需要进一步研究卵巢刺激策略以增加卵母细胞数量和提高活产率。